Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Thymoma × NET × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 14 Other solid neoplasm 10 Gastrointestinal 9 Gynecologic 8 Genitourinary 7 Breast 6 Head & Neck 5 Dermatologic 5 Endocrine 4 Sarcoma 3 CNS 2 Other hematologic neoplasm 1 NET 1 Lymphoid 1

Conditions

Neuroendocrine Tumors 49 Neoplasms 5 Gastro-enteropancreatic neuroendocrine tumor 5 Carcinoid Tumor 5 Pheochromocytoma 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Adenoma, Islet Cell 4 Urinary Bladder Neoplasms 3 Thyroid Neoplasms 3 Small Cell Lung Carcinoma 3 Paraganglioma 3 Carcinoma, Neuroendocrine 3 Carcinoma, Medullary 3 Breast Neoplasms 3 Brain Neoplasms 3 Adrenocortical Carcinoma 3 Uveal Melanoma 2 Uterine Cervical Neoplasms 2 Testicular Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Lung Neoplasms 2 Liver Neoplasms 2 Kidney Neoplasms 2 Glioblastoma 2 Cholangiocarcinoma 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04375267 2023-11-14

LuPARP

Vastra Gotaland Region

Phase 1 Unknown

EndocrineNETOther solid neoplasmThoracic

Mesothelioma, Thymoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡